These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 19318388)

  • 1. Accelerated atherosclerosis in systemic lupus erythematosus: perspectives towards decreasing cardiovascular morbidity and mortality.
    Escárcega RO; Garcia-Carrasco M; Jara LJ; Cervera R
    Lupus; 2009 Apr; 18(5):383-6. PubMed ID: 19318388
    [No Abstract]   [Full Text] [Related]  

  • 2. [ASA therapy or not?].
    Strandberg T; Vanhanen H
    Duodecim; 2002; 118(6):557-9. PubMed ID: 12232998
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic lupus erythematosus and accelerated atherosclerosis.
    Hahn BH
    N Engl J Med; 2003 Dec; 349(25):2379-80. PubMed ID: 14681501
    [No Abstract]   [Full Text] [Related]  

  • 4. Premature atherosclerosis-related central nervous system involvement in two cases of systemic lupus erythematosus.
    Zhang X; Tian X; Zhang F
    J Clin Rheumatol; 2007 Aug; 13(4):211-2. PubMed ID: 17762456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should we prescribe statin and aspirin for every diabetic patient? Is it time for a polypill?
    Wienbergen H; Senges J; Gitt AK
    Diabetes Care; 2008 Feb; 31 Suppl 2():S222-5. PubMed ID: 18227489
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular disease in lupus patients: should all patients be treated with statins and aspirin?
    Bruce IN
    Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):823-38. PubMed ID: 16150405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differentiated treatment of diabetics with an acute coronary syndrome].
    Hamm CW; Hamann A
    Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S208-10. PubMed ID: 17109250
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspirin for the primary prevention of cardiovascular events.
    Ferrini R; Clark B
    Am Fam Physician; 2002 Nov; 66(9):1737-8. PubMed ID: 12449273
    [No Abstract]   [Full Text] [Related]  

  • 9. Should all patients with systemic lupus erythematosus receive cardioprotection with statins?
    Toloza S; Urowitz MB; Gladman DD
    Nat Clin Pract Rheumatol; 2007 Oct; 3(10):536-7. PubMed ID: 17700557
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum plant sterols and atherosclerosis: is there a place for statin-ezetimibe combination?
    Radermecker RP; Scheen AJ
    J Am Coll Cardiol; 2006 Apr; 47(7):1496-7; author reply 1497-8. PubMed ID: 16580546
    [No Abstract]   [Full Text] [Related]  

  • 11. Beta-blockers post-MI reduce progression of coronary atherosclerosis - pooled IVUS trials.
    Cardiovasc J Afr; 2007; 18(4):271-2. PubMed ID: 17940676
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor necrosis factor-alpha as a potential target in the treatment of systemic lupus erythematosus: a role for the HMG-CoA reductase inhibitor simvastatin.
    Kotyla PJ; Sliwinska-Kotyla B; Kucharz EJ
    J Rheumatol; 2006 Nov; 33(11):2361-3; author reply 2363. PubMed ID: 17086617
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute coronary syndromes. Time to re-think the old paradigm.
    Chung EE
    West Indian Med J; 2000 Jun; 49(2):93-4. PubMed ID: 10948842
    [No Abstract]   [Full Text] [Related]  

  • 14. LDL-Cholesterol is the King.
    Goumas GS
    Angiology; 2009; 60(3):387-8. PubMed ID: 19497926
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of ischaemic stroke: statins and antiplatelet agents.
    Cimminiello C; Romano A
    Neurol Sci; 2005 May; 26 Suppl 1():S24-5. PubMed ID: 15883685
    [No Abstract]   [Full Text] [Related]  

  • 16. Aggressive treatment of atherosclerosis: the time is now.
    Fonarow GC
    Cleve Clin J Med; 2003 May; 70(5):431-4, 437-8, 440. PubMed ID: 12785316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry).
    Koeth O; Zahn R; Gitt AK; Bauer T; Juenger C; Senges J; Zeymer U;
    Am J Cardiol; 2009 Oct; 104(8):1074-7. PubMed ID: 19801027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Assessing the cardiovascular risk in patients with systemic lupus erythematosus].
    Arnaud L; Mathian A; Bruckert E; Amoura Z
    Rev Med Interne; 2014 Nov; 35(11):723-9. PubMed ID: 25234464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical therapy versus percutaneous coronary intervention for patients with stable coronary artery disease.
    Arbab-Zadeh A
    J Am Coll Cardiol; 2009 Feb; 53(6):528-9; author reply 529. PubMed ID: 19195616
    [No Abstract]   [Full Text] [Related]  

  • 20. Vulnerable plaque: scope of the problem.
    Wilensky RL
    J Interv Cardiol; 2008 Dec; 21(6):443-51. PubMed ID: 18973505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.